CIA
ELAN icon

Concurrent Investment Advisors’s Elanco Animal Health ELAN Stock Holding History

Concurrent Investment Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Sell
15,417
-3,155
-17% -$72.9K ﹤0.01% 1556
2026
Q1 		$444K Buy
18,572
+9,114
+96% +$223K ﹤0.01% 1279
2025
Q4 		$214K Buy
+9,458
New +$206K ﹤0.01% 1605

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Concurrent Investment Advisors's ELAN Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Elanco Animal Health (ELAN) stake by 17% in Q2 2026, selling an estimated $72.9K and leaving 15,417 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

Concurrent Investment Advisors first reported a position in ELAN in Q4 2025 and has held it in 3 quarters since. The position peaked at $444K in Q1 2026. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Concurrent Investment Advisors held 15,417 shares of Elanco Animal Health worth $379K as of Q2 2026.
  • Concurrent Investment Advisors sold 3,155 Elanco Animal Health shares in Q2 2026, an estimated $72.9K.
  • Elanco Animal Health made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1556 holding.
  • Concurrent Investment Advisors first reported a position in Elanco Animal Health in Q4 2025 and has held it in 3 quarters since.
  • Concurrent Investment Advisors's Elanco Animal Health position peaked at $444K in Q1 2026.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.